News & Information

First Patient Receives Dose of LJPC-401

PRESS RELEASE SAN DIEGO, Oct 19, 2015 (BUSINESS WIRE) — La Jolla Pharmaceutical Company LJPC, +7.39% (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that the first patient has been dosed in a Phase 1 clinical trial […]

October 20, 2015  /  Comments Off on First Patient Receives Dose of LJPC-401

Hepcidin and Host Defense against Infectious Diseases

Abstract Hepcidin is the master regulator of iron homeostasis in vertebrates. The synthesis of hepcidin is induced by systemic iron levels and by inflammatory stimuli. While the role of hepcidin in iron regulation is well established, its contribution to host defense is emerging as complex and multifaceted. In this review, we summarize the literature on […]

October 18, 2015  /  Comments Off on Hepcidin and Host Defense against Infectious Diseases

Long-time councilman recovers from illness

SEBRING — During the last couple of Sebring City Council regular and budget meetings, a familiar voice was not heard. Sebring City Councilman John Griffin, currently the longest continuously serving member, and who has never been shy about expressing his views during a City Council meeting, was absent, recovering from a surgical procedure to treat […]

October 18, 2015  /  Comments Off on Long-time councilman recovers from illness